‘Suffocating’ cancer: A new headway in melanoma immunotherapy

Source: EurekAlert!, June 2021

Hypoxia, or the inadequate oxygenation of a tissue, is a condition occurring frequently in all solid tumours such as melanoma skin cancer. Melanoma cells are not only able to survive oxygen deprivation, but also to use it to their own advantage by hijacking the anti-tumour immune response and developing resistance mechanisms to conventional anti-cancer therapies.

READ THE ORIGINAL FULL ARTICLE